PT73032B - Procede pour isoler des antigenes glycoproteiques viraux et sa application a la preparation des vaccins - Google Patents

Procede pour isoler des antigenes glycoproteiques viraux et sa application a la preparation des vaccins

Info

Publication number
PT73032B
PT73032B PT73032A PT7303281A PT73032B PT 73032 B PT73032 B PT 73032B PT 73032 A PT73032 A PT 73032A PT 7303281 A PT7303281 A PT 7303281A PT 73032 B PT73032 B PT 73032B
Authority
PT
Portugal
Prior art keywords
glycoprotetic
antigens
application
vaccine preparation
isolating viral
Prior art date
Application number
PT73032A
Other languages
English (en)
French (fr)
Other versions
PT73032A (fr
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of PT73032A publication Critical patent/PT73032A/pt
Publication of PT73032B publication Critical patent/PT73032B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PT73032A 1980-06-05 1981-05-14 Procede pour isoler des antigenes glycoproteiques viraux et sa application a la preparation des vaccins PT73032B (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8012522A FR2483779A1 (fr) 1980-06-05 1980-06-05 Procede pour isoler des antigenes glycoproteiques viraux et son application a la preparation de vaccins

Publications (2)

Publication Number Publication Date
PT73032A PT73032A (fr) 1981-06-01
PT73032B true PT73032B (fr) 1982-07-01

Family

ID=9242745

Family Applications (1)

Application Number Title Priority Date Filing Date
PT73032A PT73032B (fr) 1980-06-05 1981-05-14 Procede pour isoler des antigenes glycoproteiques viraux et sa application a la preparation des vaccins

Country Status (19)

Country Link
US (1) US4344935A (pt)
EP (1) EP0041880B1 (pt)
JP (1) JPS5726624A (pt)
AR (1) AR228865A1 (pt)
AT (1) ATE3239T1 (pt)
AU (1) AU546088B2 (pt)
CA (1) CA1174598A (pt)
DE (1) DE3160264D1 (pt)
DK (1) DK228081A (pt)
ES (1) ES8203225A1 (pt)
FI (1) FI811685L (pt)
FR (1) FR2483779A1 (pt)
GR (1) GR74610B (pt)
IE (1) IE51226B1 (pt)
IL (1) IL62913A (pt)
NO (1) NO811873L (pt)
NZ (1) NZ197306A (pt)
PT (1) PT73032B (pt)
ZA (1) ZA813479B (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4721675A (en) * 1982-02-01 1988-01-26 Abbott Laboratories Production of hepatitis A virus in vitro utilizing a persistently virus infected cell culture system
US4645666A (en) * 1982-06-08 1987-02-24 The Regents Of The University Of California Vaccine for bluetongue disease employing platinum compounds
GB8502096D0 (en) * 1985-01-28 1985-02-27 Medical Res Council Influenza vaccine
NZ224422A (en) 1987-05-05 1990-11-27 Molecular Eng Ass Composition adapted for intranasal immunisation against viral infection comprising a glycoprotein complexed with a lipid
US4909940A (en) * 1987-12-30 1990-03-20 New York Blood Center, Inc. Extraction of process chemicals from labile biological mixtures with organic alcohols or with halogenated hydrocarbons
US4975119A (en) * 1989-04-25 1990-12-04 Rheox, Inc. Liquid antisettling agents for organic coating compositions
US5741493A (en) * 1991-01-24 1998-04-21 Pasteur Merieux Serums Et Vaccins Vaccine composition against influenza, with synergic effects, containing influenza virus core as an additive
FR2671974A1 (fr) * 1991-01-24 1992-07-31 Pasteur Merieux Serums Vacc Composition vaccinale contre la grippe, a effet synergique, contenant comme additif du core de virus grippal.
US6780630B1 (en) * 1992-07-10 2004-08-24 Baylor College Of Medicine Parenteral immunization against rotavirus
FR2723740B1 (fr) * 1994-08-16 1996-11-08 Pasteur Merieux Serums Vacc Procede de preparation d'antigenes du virus grippal, antigenes obtenus et leurs applications
DE69629812T2 (de) 1995-06-14 2004-04-01 Baylor College Of Medicine, Houston Impfstoff gegen rotavirus infektionen enthaltend peptide des viralenterotoxines nsp4
US6673355B1 (en) 1995-06-14 2004-01-06 Baylor College Of Medicine Rotavirus enterotoxin NSP4 and methods of using same
DE19938767C2 (de) * 1999-08-16 2002-10-24 Tad Pharma Gmbh Spaltimpfstoffe

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE661402A (pt) 1964-03-20
US3847737A (en) * 1965-03-22 1974-11-12 A Kanarek Inactivation of myxoviruses and method of preparing a vaccine therefrom
US3629470A (en) * 1968-04-08 1971-12-21 Burroughs Wellcome Co Process for purification of animal rna viruses
BR6915288D0 (pt) * 1969-03-15 1973-02-08 Bayer Ag Processo para a purificacao de solucoes do virus da febre aftosa
US3989818A (en) * 1970-08-14 1976-11-02 South African Inventions Development Corporation Influenza virus vaccine
US3790552A (en) * 1972-03-16 1974-02-05 Us Health Method of removing hepatitis-associated antigen from a protein fraction using polyethylene glycol
US3962421A (en) * 1973-06-18 1976-06-08 American Home Products Corporation Method for the disruption of lipid-containing viruses
GB1486557A (en) 1973-10-18 1977-09-21 Flockhart & Co Process for the preparation of pyrogen-free sub-unit vaccine
US3951937A (en) * 1973-12-20 1976-04-20 The Community Blood Council Of Greater New York, Inc. Large scale purification of hepatitis type B antigen using polyethylene glycol
US4140762A (en) * 1974-01-14 1979-02-20 Sandoz Ltd. Influenza sub-unit vaccine
US4064232A (en) * 1974-01-14 1977-12-20 Sandoz Ltd. Process for isolating the immunogenic components of influenza viruses
AU507149B2 (en) 1975-01-16 1980-02-07 Mount Sinai School Of Medicine Of The City University Of New York, The Method of influenza immunization
FR2422720A2 (fr) 1977-04-26 1979-11-09 Elf Aquitaine Separation et purification de proteines par chromatographie
FI66020C (fi) * 1977-09-19 1984-08-10 Merck & Co Inc Foerfarande foer framstaellning av antigeniska immunogeniska subunits av hsv-1 och hsv-2
DE2750045A1 (de) * 1977-11-09 1979-05-10 Behringwerke Ag Verfahren zur entfernung von detergentien aus virusantigensuspensionen

Also Published As

Publication number Publication date
DE3160264D1 (en) 1983-06-16
JPS5726624A (en) 1982-02-12
AR228865A1 (es) 1983-04-29
AU546088B2 (en) 1985-08-15
IE51226B1 (en) 1986-11-12
EP0041880A1 (fr) 1981-12-16
ES502549A0 (es) 1982-04-01
FR2483779A1 (fr) 1981-12-11
DK228081A (da) 1981-12-06
ZA813479B (en) 1982-06-30
US4344935A (en) 1982-08-17
FI811685L (fi) 1981-12-06
IL62913A0 (en) 1981-07-31
GR74610B (pt) 1984-06-29
CA1174598A (en) 1984-09-18
NO811873L (no) 1981-12-07
FR2483779B1 (pt) 1983-07-22
PT73032A (fr) 1981-06-01
NZ197306A (en) 1984-03-16
ES8203225A1 (es) 1982-04-01
EP0041880B1 (fr) 1983-05-11
ATE3239T1 (de) 1983-05-15
IE811168L (en) 1981-12-05
AU7117081A (en) 1981-12-10
IL62913A (en) 1984-08-31

Similar Documents

Publication Publication Date Title
PT73032B (fr) Procede pour isoler des antigenes glycoproteiques viraux et sa application a la preparation des vaccins
FR2344629A1 (fr) Procede pour la purification et l'isolement de virus de l'hepatite utilisable pour la preparation d'un vaccin
FR2532179B1 (fr) Preparation pharmaceutique pour ameliorer les symptomes du cancer
BE856355A (fr) Procede pour combattre les infections virales
MC1811A1 (fr) Extrait de plantes de l'espece nerium procede pour sa preparation et ses applications
BE831991A (fr) Fibres englobant des anticorps, des antigenes, des antiserums, procede pour leur preparation et leurs emplois
BE877323A (fr) Acide silicique precipite contenant du bore et procede pour sa preparation
LU81086A1 (fr) Procede de preparation de tetrahydrobenzoxocines et de cis-hexahydrodibenzopyranones
LU81482A1 (fr) Procede de preparation de d-camphorate de l-carnitinamide et de d-camphorate de d-carnitinamide
BE866096A (fr) Antigene du noyau d'hepatite b et procede pour sa preparation
JPS5671023A (en) Method of passively adsorbing immune response hapten to solid phase
PH18636A (en) Method of purifying nucleolar antigens
PT73210A (fr) Procede pour la preparation de benzamides substituees et compositions pharmaceutiques qui les contiennent
FR2322643A1 (fr) Procede de separation chromatographique des isotopes d'uranium
BE846822A (fr) Procede pour deceler l'antigene et les anticorps de l'hepatite et vaccin contre l'hepatite
PT68275A (fr) Procede pour la preparation de vaccins contre les maladiesprovoquees par des paramixovirus
JPS5781415A (en) Single strain vaccine for infectious disease by some strains of cilia bacteria
FR2308401A1 (fr) Procede de separation des isotopes de l'uranium par excitation infrarouge
RO83438A (ro) Procedeu pentru prepararea unor bis-tetrazolmetiltioli
FR2302296A1 (fr) Bis-(guanidinium)-tetrabromodiane et procede pour sa preparation
FR2589063B1 (fr) Procede de culture de babesia canis, application a la preparation d'antigenes et de vaccins, et antigenes et vaccins contre la piroplasmose
JPS5547124A (en) Method for separation of isotopes
BE891229A (fr) Nouveaux 2-aminoethanols et procede pour leur preparation
RO81684A (ro) Procedeu pentru prepararea unor benzolamine
RO81694A (ro) Procedeu pentru prepararea unor 2-haloacetamidometileneteri substituiti